Randomized, double-blind, placebo-controlled oxytocin and dose-response trial in children with Prader-Willi syndrome. Effects on social behaviour.
Phase of Trial: Phase II/III
Latest Information Update: 28 Dec 2017
Price : $35 *
At a glance
- Drugs Oxytocin (Primary)
- Indications Prader-Willi syndrome
- Focus Pharmacodynamics
- 31 Aug 2018 Biomarkers information updated
- 23 Dec 2017 Status changed from not stated to recruiting.
- 09 Oct 2017 New trial record